{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:40:21Z","timestamp":1787946021585,"version":"build-2784847793"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009924","name":"Air Force Institute of Technology","doi-asserted-by":"publisher","award":["PLTTI20912"],"award-info":[{"award-number":["PLTTI20912"]}],"id":[{"id":"10.13039\/100009924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009924","name":"Air Force Institute of Technology","doi-asserted-by":"publisher","award":["MOBJD1072"],"award-info":[{"award-number":["MOBJD1072"]}],"id":[{"id":"10.13039\/100009924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"publisher","award":["PRG1506"],"award-info":[{"award-number":["PRG1506"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"publisher","award":["PRG1169"],"award-info":[{"award-number":["PRG1169"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"publisher","award":["PRG1259"],"award-info":[{"award-number":["PRG1259"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.biopha.2025.117872","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:05:49Z","timestamp":1738353949000},"page":"117872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides"],"prefix":"10.1016","volume":"184","author":[{"given":"Abhijit","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7301-2246","authenticated-orcid":false,"given":"Kapilraj","family":"Periyasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1117-3591","authenticated-orcid":false,"given":"Maria","family":"Maloverjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4664-4560","authenticated-orcid":false,"given":"Ly","family":"Porosk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhichan","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1548-1654","authenticated-orcid":false,"given":"Hanna","family":"Andla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raivo","family":"Raid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9765-055X","authenticated-orcid":false,"given":"Vambola","family":"Kisand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margus","family":"R\u00e4tsep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Wengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rebane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margus","family":"Pooga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117872_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2021.113834","article-title":"Nucleic acid delivery for therapeutic applications","volume":"178","author":"Gupta","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.117872_bib2","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.117872_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biopha.2025.117872_bib4","unstructured":"Our approach to nucleotide-based therapeutics. \u3008https:\/\/www.astrazeneca.com\/r-d\/next-generation-therapeutics\/nucleotide-based-therapeutics\u3009, in, (accessed 2023-07-23)."},{"key":"10.1016\/j.biopha.2025.117872_bib5","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.117872_bib6","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1172\/JCI76175","article-title":"Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model","volume":"124","author":"Bestas","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.117872_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA Versus miRNA as therapeutics for gene silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2025.117872_bib8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nbt739","article-title":"siRNA-mediated gene silencing in vitro and in vivo","volume":"20","author":"Xia","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2025.117872_bib9","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/mt.2016.143","article-title":"Viral and synthetic RNA vector technologies and applications","volume":"24","author":"Schott","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2025.117872_bib10","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1021\/acsami.8b13794","article-title":"Engineered histidine-enriched facial Lipopeptides for enhanced intracellular delivery of functional siRNA to triple negative breast Cancer cells","volume":"11","author":"Biswas","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.117872_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jconrel.2021.11.032","article-title":"Emerging landscape of cell-penetrating peptide-mediated nucleic acid delivery and their utility in imaging, gene-editing, and RNA-sequencing","volume":"341","author":"Geng","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2025.117872_bib12","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3390\/molecules22111929","article-title":"Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity","volume":"22","author":"Kalafatovic","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.117872_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-2806-4_1","article-title":"Classes of cell-penetrating peptides","author":"Pooga","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2025.117872_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111116","article-title":"Uptake pathways of cell-penetrating peptides in the context of drug delivery, gene therapy, and vaccine development","author":"Dowaidar","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biopha.2025.117872_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/ijms17020185","article-title":"Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos","volume":"17","author":"Kristensen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117872_bib16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/cbdd.12008","article-title":"Cell-penetrating peptides as a novel transdermal drug delivery system","volume":"80","author":"Nasrollahi","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2025.117872_bib17","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1021\/bc200293d","article-title":"Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo","volume":"22","author":"Suhorutsenko","year":"2011","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biopha.2025.117872_bib18","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1093\/nar\/gkr072","article-title":"PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation","volume":"39","author":"Ezzat","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.117872_bib19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/cells11040756","article-title":"Divalent metal ions boost effect of nucleic acids delivered by cell-penetrating peptides","volume":"11","author":"Maloverjan","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.117872_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120316","article-title":"NickFect type of cell-penetrating peptides present enhanced efficiency for microRNA-146a delivery into dendritic cells and during skin inflammation","volume":"262","author":"Carreras-Badosa","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117872_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jconrel.2016.06.006","article-title":"Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis","volume":"235","author":"Urgard","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.117872_bib22","doi-asserted-by":"crossref","first-page":"17056","DOI":"10.1038\/s41598-017-17316-y","article-title":"Effective in vivo gene delivery with reduced toxicity, achieved by charge and fatty acid-modified cell penetrating peptide","volume":"7","author":"Kurrikoff","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117872_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1021\/mp3003557","article-title":"PepFect14 peptide vector for efficient gene delivery in cell cultures","volume":"10","author":"Veiman","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.117872_bib24","doi-asserted-by":"crossref","first-page":"1219761","DOI":"10.3389\/fphar.2023.1219761","article-title":"PepFect14 mediates the delivery of mRNA into human primary keratinocytes and in vivo","volume":"14","author":"Periyasamy","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117872_bib25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/acs.bioconjchem.6b00680","article-title":"Saturated fatty acid analogues of cell-penetrating peptide PepFect14: role of fatty acid modification in complexation and delivery of splice-correcting oligonucleotides","volume":"28","author":"Lehto","year":"2017","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biopha.2025.117872_bib26","series-title":"Department of Biochemistry and Biophysics","article-title":"PepFect14, a Versatile cell-penetrating peptide","author":"Gestin","year":"2020"},{"key":"10.1016\/j.biopha.2025.117872_bib27","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.bbamem.2015.09.019","article-title":"The role of endocytosis in the uptake and intracellular trafficking of PepFect14\u2013nucleic acid nanocomplexes via class A scavenger receptors","volume":"1848","author":"Juks","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"10.1016\/j.biopha.2025.117872_bib28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/ph14070667","article-title":"Internalisation and biological activity of nucleic acids delivering cell-penetrating peptide nanoparticles is controlled by the biomolecular corona","volume":"14","author":"Lorents","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.117872_bib29","doi-asserted-by":"crossref","first-page":"12635","DOI":"10.1038\/s41598-017-12747-z","article-title":"Role of autophagy in cell-penetrating peptide transfection model","volume":"7","author":"Dowaidar","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117872_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228189","article-title":"Effect of small molecule signaling in PepFect14 transfection","volume":"15","author":"Gestin","year":"2020","journal-title":"PLOS One"},{"key":"10.1016\/j.biopha.2025.117872_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2016.01.055","article-title":"pH-responsive PepFect cell-penetrating peptides","volume":"501","author":"Regberg","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2025.117872_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1096\/fba.1026","article-title":"Tumor gene therapy by systemic delivery of plasmid DNA with cell-penetrating peptides","volume":"1","author":"K\u00fcnnapuu","year":"2019","journal-title":"Faseb Bioadv."},{"key":"10.1016\/j.biopha.2025.117872_bib33","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1021\/bi970272n","article-title":"Thermodynamics of oligoarginines binding to RNA and DNA","volume":"36","author":"Mascotti","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2025.117872_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/nat.2016.0631","article-title":"Four novel splice-switch reporter cell lines: distinct impact of oligonucleotide chemistry and delivery vector on biological activity","volume":"26","author":"Rocha","year":"2016","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.biopha.2025.117872_bib35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ab.2015.05.023","article-title":"Optimized luciferase assay for cell-penetrating peptide-mediated delivery of short oligonucleotides","volume":"484","author":"Helmfors","year":"2015","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2025.117872_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167604","article-title":"MLCPP 2.0: an updated cell-penetrating peptides and their uptake efficiency predictor","volume":"434","author":"Manavalan","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2025.117872_bib37","article-title":"Peptide sondary structure prediction using evolutionary information","author":"Singh","year":"2019","journal-title":"BioRxiv"},{"key":"10.1016\/j.biopha.2025.117872_bib38","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/pharmaceutics15020396","article-title":"Choosing an optimal solvent is crucial for obtaining cell-penetrating peptide nanoparticles with desired properties and high activity in nucleic acid delivery","volume":"15","author":"Biswas","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.117872_bib39","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1021\/bi980300h","article-title":"Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development","volume":"37","author":"Kang","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2025.117872_bib40","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1093\/nar\/29.19.3965","article-title":"Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs","volume":"29","author":"Sazani","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.117872_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.427","article-title":"Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbation","volume":"11","author":"Laanesoo","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biopha.2025.117872_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1144-x","article-title":"Targeted gene silencing in human embryonic stem cells using cell-penetrating peptide PepFect 14","volume":"10","author":"Ervin","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2025.117872_bib45","doi-asserted-by":"crossref","first-page":"11314","DOI":"10.1096\/fj.201900263R","article-title":"The nuclear concentration required for antisense oligonucleotide activity in myotonic dystrophy cells, The","volume":"33","author":"Van Der Bent","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2025.117872_bib46","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1021\/jacs.0c03039","article-title":"Selective modification of tryptophan residues in peptides and proteins using a biomimetic electron transfer process","volume":"142","author":"Tower","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2025.117872_bib47","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1021\/jm0105676","article-title":"Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake","volume":"45","author":"Rothbard","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.117872_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0005-2736(00)00216-9","article-title":"Deletion analogues of transportan","volume":"1467","author":"Soomets","year":"2000","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"10.1016\/j.biopha.2025.117872_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1389203033487252","article-title":"Guanidinium rich peptide transporters and drug delivery","volume":"4","author":"Wright","year":"2003","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.biopha.2025.117872_bib50","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/pharmaceutics15030883","article-title":"Modification of the linker amino acid in the cell-penetrating peptide NickFect55 leads to enhanced pDNA transfection for in vivo applications","volume":"15","author":"H\u00e4rk","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.117872_bib51","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.bbamem.2010.03.005","article-title":"sondary structure of cell-penetrating peptides controls membrane interaction and insertion","volume":"1798","author":"Eir\u00edksd\u00f3ttir","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"10.1016\/j.biopha.2025.117872_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3762\/bjnano.11.10","article-title":"Internalization mechanisms of cell-penetrating peptides","volume":"11","author":"Ruseska","year":"2020","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.biopha.2025.117872_bib53","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/nar\/29.13.2860","article-title":"Amino acid\u2013base interactions: a three-dimensional analysis of protein\u2013DNA interactions at an atomic level","volume":"29","author":"Luscombe","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.117872_bib54","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.bbamem.2012.03.001","article-title":"Binding of cationic pentapeptides with modified side chain lengths to negatively charged lipid membranes: Complex interplay of electrostatic and hydrophobic interactions","volume":"1818","author":"Hoernke","year":"2012","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"10.1016\/j.biopha.2025.117872_bib55","doi-asserted-by":"crossref","first-page":"15948","DOI":"10.1039\/C4CC07511K","article-title":"Toll-like receptor agonist lipopeptides self-assemble into distinct nanostructures","volume":"50","author":"Hamley","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biopha.2025.117872_bib56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/acs.molpharmaceut.5b00598","article-title":"Characteristics of cell-penetrating peptide\/nucleic acid nanoparticles","volume":"13","author":"Margus","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.117872_bib57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2016.10.009","article-title":"Mechanisms of cellular uptake and endosomal escape of calcium-siRNA nanocomplexes","volume":"515","author":"Goldshtein","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2025.117872_bib58","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1096\/fj.11-191536","article-title":"Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides","volume":"26","author":"Ezzat","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2025.117872_bib59","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jaci.2014.05.022","article-title":"MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes","volume":"134","author":"Rebane","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2025.117872_bib60","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1091\/mbc.e05-02-0109","article-title":"Calcium-induced human keratinocyte differentiation requires src-and fyn-mediated phosphatidylinositol 3-kinase\u2013dependent activation of phospholipase C-\u03b31","volume":"16","author":"Xie","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.biopha.2025.117872_bib61","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jid.2017.05.012","article-title":"miR-146b probably assists miRNA-146a in the suppression of keratinocyte proliferation and inflammatory responses in psoriasis","volume":"137","author":"Hermann","year":"2017","journal-title":"J. Investig. Dermatol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T18:43:52Z","timestamp":1741027432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":59,"alternative-id":["S0753332225000666"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117872","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117872"}}